News | News By Subject | News by Disease News By Date | Search News

Tumor (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics     6/15/2017
Halozyme (HALO) CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data     4/6/2017
Before We Act Impulsively on Drug Prices We Should Make Precision Policies     4/4/2017
FDA Demands Karyopharm (KPTI) Stop Enrollment of All Selinexor Trials     3/14/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal     2/13/2017
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017     12/22/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T?     10/20/2016
Daiichi Sankyo and Plexxikon Suspend Phase III Trial of Drug for Rare Tendon Cancer     10/19/2016
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR     4/25/2016
Kite Pharma (KITE) Cancer Therapy Responses in Solid Tumors Continued in Small Trial, NCI Review Halts Patient Enrollment     4/18/2016
Fluorescence Lighting Up Clinical Research     3/3/2016
Forty Seven Launches with Half of $75 Million Series A Backed by Google (GOOG) and 100+ Patents     2/26/2016
Analyst Questions High Cost of T Cell Therapies as Potential Frontline Treatment for Blood Cancers     2/25/2016
Armed with $50 Million from Google (GOOG), Celgene (CELG) and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos     2/11/2016
Sneak Peak of Five Prime (FPRX)'s Prelim Phase I Tumor Data Leaves Investors Happy     1/22/2016

News from Around the Web
University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors     7/20/2017
New Device Detects Tumor Cells In Blood, Universitat Rovira i Virgili Study Reveals     7/18/2017
Researchers Develop Tumor-Targeting MRI Contrast Based On Human Protein, University of Massachusetts Medical School Reveals     7/10/2017
Injectable Plant-Based Nanoparticles Delay Tumor Progression, Case Western Reserve University School of Medicine Study     6/29/2017
New MRI Technique Images Glucose In Body To Spot Tumors, German Cancer Research Center (DKFZ) Study Reveals     6/29/2017
Microscope Can Scan Tumors During Surgery And Examine Cancer Biopsies In 3-D, University of Washington Study Reveals     6/28/2017
A Mechanical Trigger For Toxic Tumor Therapy, Harvard Medical School Study     6/16/2017
Scientists Move Closer To Detecting Cancer Long Before Any Symptoms Appear, GRAIL Reveals     6/12/2017
A 'Sci-Fi' Cancer Therapy Fights Brain Tumors, Study Finds     4/3/2017
Toward Glow-In-The-Dark Tumors: New Fluorescent Probe Could Light Up Cancer, Michigan Tech Study Reveals     3/30/2017
New Technique Provides Quick Tumor Diagnosis During Brain Surgeries, University of Michigan Study     2/9/2017
Miniature Brain And Skull Found Inside 16-Year-Old Girl's Ovary, Shiga Medical Centre Study     1/11/2017
How Strata Oncology Plans To Sequence 100K Tumors For Free     12/22/2016
SurgVision Displays Tumors During Surgery     12/14/2016
New Invention: An Implantable Capsule For Killing Tumors, Houston Methodist Research Institute Study     12/13/2016

Press Releases
Medivir (MVRBF) Initiates Clinical Study Of Birinapant In Combination With KEYTRUDA (Pembrolizumab) In Patients With Treatment-Refractory Solid Tumours     8/18/2017
Publication In EMBO Molecular Medicine Demonstrates CureVac's Proprietary mRNA Technology Enables Antibody Mediated Therapies Against Infectious Agents, Toxins And Tumors     8/15/2017
Detection Of Circulating Tumor Cells In Breast Cancer Patients Using The GILUPI CellCollector     8/9/2017
BioLife Solutions, Inc. (BLFS.OB) Executes Supply Agreement With Celyad For CryoStor Use In Natural Killer Receptor Based T-Cell (NKR-T) Platform Targeting Solid Tumors And Blood Cancers     7/31/2017
Qfix Launches ZiFix Abdominal / Thoracic Motion Control System     7/28/2017
NewLink Genetics (NLNK) Announces First Patient Dosed In Phase I Study Of IDO Pathway Inhibitor NLG802     7/27/2017
TrovaGene (TROV) Announces Peer-Reviewed Publication Of First-In-Human Phase I Trial Results With PCM-075, Its Polo-Like Kinase 1 (PLK1) Inhibitor     7/25/2017
Aptevo Therapeutics (APVO) And Alligator Bioscience Announce Plans To Co-Develop Novel Bispecific Antibody For Tumor-Directed Immunotherapy     7/21/2017
Angle: Preclinical Study Presented At Tumor Boston Summit     7/20/2017
NYU Langone Medical Center Release: Partnering Cells Turn Off Immune Attack on Pancreatic Tumors     7/19/2017
Alpha Tau Medical Secures Second Funding Round To Treat Solid Tumors With Alpha Radiation     7/19/2017
Kitov (KTOV) Announces Results Of Study Demonstrating NT-219 Enhanced Efficacy Of Keytruda In Immune-Oncology Preclinical Model     7/18/2017
Apexigen Announces First Patient Dosed In Phase Ib/II Clinical Trial Of APX005M In Combination With Opdivo (Nivolumab) In Advanced Solid Tumors     7/17/2017
Amgen (AMGN) And Allergan (AGN) To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin (Bevacizumab)     7/13/2017
Syndax Release: Preclinical Results Support Entinostat's Role In Targeting The Tumor Microenvironment To Enhance Immune Checkpoint Therapy     7/12/2017